MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS PROGRIP; MESH, SURGICAL, POLYMERIC

Model Number	TEM1409GL
Medical Device Problem Codes	Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Bruise/Contusion (1754); Emotional Changes (1831); Fatigue (1849); Hematoma (1884); Inflammation (1932); Muscle Weakness/Atrophy (1967); Necrosis (1971); Pain (1994); Scar Tissue (2060); Urinary Retention (2119); Hernia (2240); Discomfort (2330); Numbness (2415); Erectile Dysfunction (4511); Unspecified Tissue Injury (4559); Urinary Incontinence (4572); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal and an umbilical hernia.It was reported that after implant, the patient experienced hernia recurrence, pain, and discomfort.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal and an umbilical hernia.It was reported that after implant, the patient experienced hernia recurrence, pain, mental pain, permanent impairment, loss of enjoyment of life, defective mesh, failure of mesh, scarring, inflammation, and discomfort.
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Additional Manufacturer Narrative
Additional information: b5, h6 (patient codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
Pli-10: the patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal and an umbilical hernia.It was reported that after implant, the patient experienced hernia recurrence, pain, mental pain, permanent impairment, loss of enjoyment of life, defective mesh, failure of mesh, scarring, inflammation, necrosis, and discomfort.Pli-20: the patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal and an umbilical hernia.It was reported that after implant, the patient experienced hernia recurrence, pain, mental pain, permanent impairment, loss of enjoyment of life, scarring, inflammation, necrosis, and discomfort.
Additional Manufacturer Narrative
Additional info: b6, <(>&<)> b7.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal and a ventral umbilical hernia.It was reported that after implant, the patient experienced hernia recurrence, pain, mental pain, permanent impairment, loss of enjoyment of life, defective mesh, failure of mesh, scarring, inflammation, necrosis, discomfort, hematoma, pinching sensation under testicles, numbness, black and blue appearance of penis following surgery, urinary incontinence, leaking sensation, urinary retention, weak urinary stream, stamina and weakness issues, and erectile dysfunction.Post-operative treatment included revision surgery.
Additional Manufacturer Narrative
Additional information: a4, b2, b5, b7, d10, g1, h6 (ime codes, ime e2402: weak urinary stream).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.

• Brand Name: PROGRIP
• Common Device Name: MESH, SURGICAL, POLYMERIC
• Manufacturer (Section D): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer (Section G): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer Contact: mike bocchino ; 8200 coral sea st ne; 8200 coral sea st ne; mounds view,mn, CO 55112-4391 ; 8006464633
• MDR Report Key: 12431063
• Report Number: 9615742-2021-02159
• Device Sequence Number: 3245270
• Product Code: FTL
• UDI-Device Identifier: 10884521177703
• UDI-Public: 10884521177703
• Combination Product (Y/N): N
• Initial Reporter State: MA
• Initial Reporter Country: US
• PMA/510(K) Number: K081050
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Consumer
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup,Followup,Followup
• Report Date (Section B): 08/11/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: TEM1409GL
• Device Catalogue Number: TEM1409GL
• Was Device Available for Evaluation?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/18/2021
• Supplement Date Received by Manufacturer: 03/30/2022; 01/15/2025; 06/18/2025; 08/06/2025
• Initial Report FDA Received Date: 09/06/2021
• Supplement Report FDA Received Date: 04/19/2022; 01/17/2025; 06/24/2025; 08/11/2025
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: PARIETEX MESH, PRODUCT ID: PCO4VP
• Outcome Attributed to Adverse Event: Other; Disability; Required Intervention
• Patient Sex: Male
• Patient Weight: 94 KG